Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

Shabnam Shalapour,Xue-Jia Lin,Ingmar N. Bastian,John Brain,Alastair D. Burt,Alexander A. Aksenov,Alison F. Vrbanac,Weihua Li,Andres Perkins,Takaji Matsutani,Zhenyu Zhong,Debanjan Dhar,Jose A. Navas-Molina,Jun Xu,Rohit Loomba,Michael Downes,Ruth T. Yu,Ronald M. Evans,Pieter C. Dorrestein,Rob Knight,Christopher Benner,Quentin M. Anstee,Michael Karin

DOI: https://doi.org/10.1038/nature24302

IF: 64.8

2017-11-08

Nature

Abstract:IgA+ B cells expressing programmed death ligand 1 (PD-L1) and interleukin 10 accumulate in the inflamed livers of humans and mice with non-alcoholic fatty liver disease where they promote the progression to hepatocellular carcinoma by limiting the local activation of PD-1-expressing CD8+ T cells.

multidisciplinary sciences